Allergan rises as Goldman Sachs says the stock is 'primed for growth'

Allergan rose nearly 3 percent after Goldman Sachs released a very bullish note on the stock.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.